In this study, we found that Fibroblast growth factor receptor 1 (FGFR1), which is amplified in lung and breast cancer, was downregulated in bladder cancer samples compared with that of the controls (20, 21). This evidence concerns the gene FGFR1 and urinary bladder carcinoma.